Entelexo Biotherapeutics Funding & Investors

Irvine, CA

Entelexo Biotherapeutics develops treatments intended to assist in the treatment of immune-mediated diseases. Its treatment includes a new class of drugs which include extracellular vesicles (EVs) that are derived from stem cells, enabling healthcare workers to treat autoimmune diseases.